ISLAMABAD: Even five years after COVID-19 first emerged in the U.S., the virus continues to take hundreds of lives every week.
Recent data from the Centers for Disease Control and Prevention (CDC) reveals that about 350 people are still dying weekly from COVID.
Although this number is significantly lower than the peak in early 2021, it highlights that COVID remains a serious health concern—especially for vulnerable populations.
Why Are COVID Deaths Still Occurring?
COVID Is Still Circulating
Experts emphasize that ongoing deaths signal that COVID-19 is still actively spreading.
According to Dr. Tony Moody from Duke University, the virus continues to infect people, particularly those at higher risk.
Low Vaccination Rates
A major factor contributing to ongoing deaths is the relatively low uptake of updated COVID vaccines.
Only about 23% of adults and 13% of children received the latest vaccine during the 2024-25 season.
Without widespread immunity, more people remain vulnerable.
Waning Immunity
Even vaccinated individuals may face reduced protection over time. Immunity from vaccines declines, increasing the chances of infection.
This is why boosters are recommended, especially for those aged 65 and older, who should get two doses spaced six months apart.
The High-Risk Factor: Age and Health Conditions
Older adults, particularly those over 75, face the highest rates of COVID-related deaths.
Aging weakens the immune system’s response, making it harder to fight infections.
Additionally, older individuals often have underlying health conditions that increase the risk of severe illness and death.
Challenges in Accessing COVID Treatments
Effective Treatments Are Available
Antiviral medications like Pfizer’s Paxlovid and Merck’s molnupiravir can reduce the severity of COVID-19 if taken early—within five days of symptom onset.
Remdesivir, an intravenous drug, is also effective when started promptly.
Underutilization of Therapies
Despite the availability of these treatments, many patients do not receive timely care.
Delays in testing or seeking medical help reduce opportunities to use these lifesaving medications effectively.
Dr. Moody notes that more people could benefit if treatments were used more consistently.
Moving Forward: Protecting Vulnerable Populations
To reduce COVID fatalities further, increasing vaccination rates, encouraging timely testing, and ensuring access to antiviral treatments are critical steps.
High-risk individuals should remain vigilant and follow public health guidance to protect themselves.
